Laboratory Medicine ›› 2017, Vol. 32 ›› Issue (4): 308-310.DOI: 10.3969/j.issn.1673-8640.2017.04.014
• Orginal Article • Previous Articles Next Articles
Received:2016-12-17
Online:2017-04-20
Published:2017-05-01
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2017.04.014
| 组别 | CA153（U/mL） | CEA（ng/mL） | 铁蛋白（ng/mL） | 降钙素（pg/mL） |
|---|---|---|---|---|
| 正常对照组 | 7.9±4.3 | 1.5±0.2 | 35.8（22.7~46.4） | 1.2±0.1 |
| 乳腺良性肿块组 | 11.9±4.6*** | 2.1±0.9*** | 72.9（31.5~105.4）** | 2.2±0.5* |
| 乳腺癌组 | 15.2±10.8*** | 2.2±1.3** | 109.6（51.75~197.2）***# | 3.5±0.7*** |
| 组别 | CA153（U/mL） | CEA（ng/mL） | 铁蛋白（ng/mL） | 降钙素（pg/mL） |
|---|---|---|---|---|
| 正常对照组 | 7.9±4.3 | 1.5±0.2 | 35.8（22.7~46.4） | 1.2±0.1 |
| 乳腺良性肿块组 | 11.9±4.6*** | 2.1±0.9*** | 72.9（31.5~105.4）** | 2.2±0.5* |
| 乳腺癌组 | 15.2±10.8*** | 2.2±1.3** | 109.6（51.75~197.2）***# | 3.5±0.7*** |
| 病理分级 | CA153（U/mL） | CEA（ng/mL） | 铁蛋白（ng/mL） | 降钙素（pg/mL） |
|---|---|---|---|---|
| Ⅰ~Ⅱ级 | 14.9±8.6 | 2.2±0.8 | 98.9（54.5~183.4） | 3.4±0.3 |
| Ⅲ级 | 15.3±9.8 | 2.3±1.0 | 100.6（50.05~199.2） | 3.6±0.6 |
| 病理分级 | CA153（U/mL） | CEA（ng/mL） | 铁蛋白（ng/mL） | 降钙素（pg/mL） |
|---|---|---|---|---|
| Ⅰ~Ⅱ级 | 14.9±8.6 | 2.2±0.8 | 98.9（54.5~183.4） | 3.4±0.3 |
| Ⅲ级 | 15.3±9.8 | 2.3±1.0 | 100.6（50.05~199.2） | 3.6±0.6 |
| 项目 | 敏感性 | 特异性 | 阳性似然比 | 阴性似然比 | ROC曲线下面积（95%可信区间） |
|---|---|---|---|---|---|
| CA153 | 54.6 | 90.7 | 8.7 | 0.49 | 0.663（0.561~0.766） |
| CEA | 41.2 | 92.5 | 5.5 | 0.64 | 0.557（0.471~0.643） |
| 铁蛋白 | 71.1 | 68.5 | 14.7 | 0.25 | 0.829（0.768~0.890） |
| 降钙素 | 22.5 | 73.2 | 4.6 | 0.71 | 0.531（0.436~0.626） |
| 联合检测 | 81.2 | 95.0 | 16.3 | 0.20 | 0.871（0.817~0.926） |
| 项目 | 敏感性 | 特异性 | 阳性似然比 | 阴性似然比 | ROC曲线下面积（95%可信区间） |
|---|---|---|---|---|---|
| CA153 | 54.6 | 90.7 | 8.7 | 0.49 | 0.663（0.561~0.766） |
| CEA | 41.2 | 92.5 | 5.5 | 0.64 | 0.557（0.471~0.643） |
| 铁蛋白 | 71.1 | 68.5 | 14.7 | 0.25 | 0.829（0.768~0.890） |
| 降钙素 | 22.5 | 73.2 | 4.6 | 0.71 | 0.531（0.436~0.626） |
| 联合检测 | 81.2 | 95.0 | 16.3 | 0.20 | 0.871（0.817~0.926） |
| [1] | LAMB R,BONUCCELLI G,OZSVáRI B,et al. Mitochondrial mass,a new metabolic biomarker for stem-like cancer cells:understanding WNT/FGF-driven anabolic signaling[J]. Oncotarget,2015,6(31):30453-30471. |
| [2] | BAO L,CARDIFF R D,STEINBACH P,et al.Multipotent luminal mammarycancer stem cells model tumor heterogeneity[J]. Breast Cancer Res,2015,17(1):137. |
| [3] | ASPARUHOVA M B,SECONDINI C,RüEGG C,et al. Mechanism of irradiation-induced mammary cancer metastasis:a role for SAP-dependent Mkl1 signaling[J]. Mol Oncol,2015,9(8):1510-1527. |
| [4] | LAKSHMINARAYANAN V,THOMPSON P,WOLFERT M A,et al.Immune recognition of tu-mor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine[J]. Proc Natl Acad Sci U S A,2012,109(1):261-266. |
| [5] | CAMPOS L C,LAVALLE G E,ESTRELA-LIMA A,et al.CA15. 3,CEA and LDH in dogs with malignant mammary tumors[J]. J Vet Intern Med,2012,26(6):1383-1388. |
| [6] | 王建国,王贯宇,吴煜龙,等. 乳腺癌肿瘤标志物CA15-3和CEA联合检测的临床意义[J]. 医学研究与教育,2011,28(1):35-37. |
| [7] | 宋现让,王丽莉,丁艳涛,等. CA15-3、CA19-9、CA24-2、CA125和CEA在乳腺癌诊断中的应用[J]. 癌症,2001,20(3):328-329. |
| [8] | GION M,MIONE R,LEON A E,et al.Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancer[J]. Clin Chem,1999,45(5):630-637. |
| [9] | 贾晓娟,许建林,杨琪,等. CA15-3在乳腺癌中的临床意义[J]. 陕西肿瘤医学,2001,9(4):236-237. |
| [10] | 詹红泉. CEA CA153 CA125 CA199 CYFRA21-1联合检测乳腺癌的诊断价值[J]. 浙江临床医学,2016,18(3):555-556. |
| [11] | 徐庆华,舒向芳,胡涛. 血清CA15-3、CEA 和PRL联合检测在乳腺癌早期诊断中的意义[J]. 中国实验诊断学,2015,19(4):647-648. |
| [12] | 易琳,刘兴明,林丁,等. 血清CA153、CA125、CEA联合检测在乳腺癌诊断中的价值[J]. 重庆医科大学学报,2012,37(9):802-805. |
| [13] | 吴祥德. 乳腺疾病诊治[M]. 北京:人民卫生出版社,2000:170-176. |
| [14] | UIBRICH E J,LEBRECHT A,SCHNEIDER I,et a1. Serum parameters of iron metabolism in patients with breast cancer[J]. Anticancer Res,2003,23(6D):5107-5109. |
| [15] | GILLESPIE M T,THOMAS R J,PU Z Y,et al.Calcitonin receptors,bone sialoprotein and osteopontin are expressed in primary breast cancers[J].Int J Cancer,1997,73(6):812-815. |
| [16] | 史春云,王淑仙,冯惠清. 肿瘤标志物CA15-3、CEA和CA125与乳腺癌关系的研究进展[J]. 医学研究与教育,2012,29(3):49-52. |
| [17] | 陈士华. 联合检测CA15-3、CA125、CEA对乳腺癌的临床价值探讨[J]. 检验医学,2013,28(3):235-237. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
